v3.26.1
DEBT (Tables)
6 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Schedule of Long-Term Debt and Effective Interest Rates
Our indebtedness as of March 31, 2026 and September 30, 2025 is detailed in the table below. Refer below for discussion of the revolving credit facility.

March 31, 2026September 30, 2025
Seller Note – Bolder BioPath (Related party)$38 $150 
Seller Payable - Orient BioResource Center3,235 3,235 
Second Lien Notes26,232 23,220 
Convertible Senior Notes119,897 116,440 
Term Loan Facility, DDTL and Incremental Term Loans266,874 268,654 
Total debt before unamortized debt issuance costs$416,276 $411,699 
Less: Debt issuance costs not amortized(5,854)(9,576)
Total debt, net of unamortized debt issuance costs$410,422 $402,123 
Less: Current portion(410,422)(402,123)
Total Long-term debt$— $— 
Below are the weighted-average effective interest rates for the loans available under the Credit Agreement:

Three Months Ended
March 31,
Six Months Ended
March 31,
2026202520262025
Effective interest rates:
Term Loan11.66 %11.52 %11.62 %11.62 %
Initial DDTL11.65 %11.51 %11.61 %11.60 %
Additional DDTL11.69 %11.63 %11.65 %11.73 %